Pitolisant Trialed for Obstructive Sleep Apnea in Japan
Aculys Pharma Inc has initiated a phase 3 clinical study in Japan of pitolisant in patients with OSA who have excessive daytime sleepiness.
Read MoreAculys Pharma Inc has initiated a phase 3 clinical study in Japan of pitolisant in patients with OSA who have excessive daytime sleepiness.
Read MoreInvestigators affiliated with Avadel Pharmaceuticals plc published a paper describing the risk of accidental dosing errors with oxybate.
Read More